2022 Insights on Cough, Cold and Allergy (Hay Fever) Remedies in the United States: Growth for Cough and Cold Medications Due to the Rise of Respiratory Illnesses – ResearchAndMarkets.com

2022 Insights on Cough, Cold and Allergy (Hay Fever) Remedies in the United States: Growth for Cough and Cold Medications Due to the Rise of Respiratory Illnesses – ResearchAndMarkets.com




2022 Insights on Cough, Cold and Allergy (Hay Fever) Remedies in the United States: Growth for Cough and Cold Medications Due to the Rise of Respiratory Illnesses – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cough, Cold and Allergy (Hay Fever) Remedies in the US” report has been added to ResearchAndMarkets.com’s offering.

Over a year since FDA approval to switch to the OTC market, allergy nasal spray Astepro is now available at retail locations. Astepro is the first and only 24-hour over-the-counter antihistamine nasal spray that is steroid-free.

The 0.15% strength of its active ingredient, azelastine, was the only formulation to be approved for the treatment of rhinitis, and its 0.1% strength formulation for children younger than six remains a prescription product.

The Cough, Cold and Allergy (Hay Fever) Remedies in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination – Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Key Topics Covered:

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE US

KEY DATA FINDINGS

2022 DEVELOPMENTS

  • Bayer’s Astepro hits the US market following its successful Rx-to-OTC switch
  • Growth for cough and cold medications due to the rise of respiratory illnesses
  • Still wary about COVID-19, some consumers are eager to pre-emptively treat symptoms

PROSPECTS AND OPPORTUNITIES

  • Potential for longer flu seasons could create greater opportunity for year-round sales
  • Antihistamines/allergy remedies set to perform well over the forecast period
  • Herbal/natural trend set to expand, especially for paediatric products

CATEGORY DATA

  • Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
  • Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
  • Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022
  • Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022
  • Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027
  • Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027

CONSUMER HEALTH IN THE US

EXECUTIVE SUMMARY

  • Consumer health in 2022: The big picture
  • 2022 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?

MARKET INDICATORS

  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
  • Table 8 Life Expectancy at Birth 2017-2022

MARKET DATA

  • Table 9 Sales of Consumer Health by Category: Value 2017-2022
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
  • Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
  • Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027

APPENDIX

  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
  • Summary 1 OTC: Switches 2021-2022

DISCLAIMER

DEFINITIONS

SOURCES

For more information about this report visit https://www.researchandmarkets.com/r/fkdcok

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900